Approach Resources Inc. (AREX) stock prices updated...
 

Approach Resources Inc. stock price

Approach Resources Inc. latest news:


  • 10/19/2017 16:09:21

    BRIEF-Twitter releases calendar of its safety work - blog

    * Says updating approach to make Twitter a safer place‍​ - blog

  • 10/18/2017 22:32:00

    FDA approves Gilead cancer gene therapy; price set at $373,000

    U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was developed by Gilead Science's Kite Pharma, marking the second approval for this potentially revolutionary approach to fighting cancer.

  • 10/18/2017 20:24:49

    GLOBAL MARKETS-Asia stocks approach 10-year peak, unfazed by China GDP, dollar rises

    * MSCI Asia-Pacific index near 10-yr high, Nikkei hits 21-yr peak

  • 10/18/2017 12:24:40

    BRIEF-Manitex ‍expects 2018 revenues from new products to approach $20 mln

    * Says ‍expect 2018 revenues from new product line introduced at ICUEE and other new products to approach $20 million in 2018​ Source text for Eikon: Further company coverage:

  • 10/05/2017 14:25:08

    In Shift, Justice Dept. Says Law Doesn’t Bar Transgender Discrimination

    The move was the Trump administration’s latest contraction of the Obama-era approach to civil rights enforcement.

  • 09/25/2017 06:25:01

    Salesforce says Black Friday will be busiest online shopping day in U.S. history

    Salesforce.com Inc. forecasts that this year's Black Friday will be the busiest online shopping day in U.S. history, beating Cyber Monday for the second consecutive year. The most popular time for e-commerce visits and orders is from 8pm to 10pm and, the company said in a Monday release, shoppers will have half of their shopping done by Dec. 3 and 80% done by Dec. 15. Orders placed on mobile phones will approach 40% on big shopping days like Black Friday, the company predicted, and 40% of millennials ages 18 to 36 are using voice-enabled assistants like Amazon.com Inc.'s Alexa and Apple Inc.'s Siri. Salesforce shares are about flat in premarket trading and up 38.7% for the year so far. The S&P 500 index is up 11.8% for 2017 so far.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 09/22/2017 14:41:12

    London Officials Say Uber Is Unfit To Operate In City

    The transport authority said Uber's approach and conduct "demonstrate a lack of corporate responsibility in relation to a number of issues that have public safety and security implications."

  • 09/22/2017 05:08:35

    Uber To Lose License In London: 'Not Fit And Proper,' City Says

    The issues raised by Transport for London include Uber's "approach to reporting serious criminal offences" and how it handles background checks.

  • 09/22/2017 04:31:00

    Uber's license to operate in London won't be renewed

    Uber London Ltd.'s license to operate won't be renewed, London's transportation regulator said Friday. Transport for London said its review of the service found Uber demonstrated a lack of corporate responsibility in a number of issues, including its approach to reporting serious criminal offenses. "TfL has concluded that Uber London Limited is not fit and proper to hold a private hire operator licence," TfL said in a statement. Uber's license to operate as a private hire service is set to expire on Sept. 30. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 09/12/2017 12:08:00

    China's Two Largest Tech Companies Sign A Deal Over The West's Biggest Music

    A deal between China's dominant tech companies reveals a lot about the country's approach to policing culture.

  • 09/06/2017 11:04:35

    No 10 seeks Brexit backing from business

    Downing Street has asked some of the UK's biggest firms to back the government's approach to Brexit.

  • 09/06/2017 10:28:43

    Merck to buy privately-held biotech Rigontec for 115 mln euros upfront

    Merck & Co. said Wednesday that it will acquire privately-held biotech Rigontec for €115 million ($137 million) upfront to Rigontec's shareholders and up to €349 million ($416 million) in additional milestone-contingent payments. Germany-based Rigontec develops RNA-based immunotherapeutics to treat cancer and viral diseases. The company's approach "complements our strategy and our current pipeline," said Merck Research Laboratories' Dr. Eric Rubin. "We think this is an interesting early stage deal that has potential synergy with other [immuno-oncology] agents, although there may be some safety concerns related to immune stimulation in general," said EvercoreISI analyst Umer Raffat. Raffat also noted that it's an early-stage deal: Rigontec's lead product is currently in early-stage trials with an expected readout by the end of 2019. Merck shares rose 0.5% in light trade midday Wednesday. Shares have declined 1.1% over the last three months, compared with a 1.4% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 08/31/2017 17:26:55

    Hurricane Harvey costs mount up

    Analysts say damage from the storm could approach $100bn.

  • 08/30/2017 13:59:07

    Get started: Business owners upbeat, cautious about hiring

    While many small business owners are upbeat about their companies and the economy, they're maintaining their cautious approach to hiring.        

  • 08/21/2017 11:34:00

    PM faces trade scrutiny as Japan trip looms

    Theresa May is facing pressure to transform her approach to shaping Britain's post-Brexit trade links amid scepticism from business leaders about the scale and ambition of a forthcoming trip to Japan.

  • 08/21/2017 09:39:22

    China's Great Wall eyes Fiat Chrysler bid

    The Chinese SUV maker says it is interested in buying the Jeep owner, but no approach has been made.

  • 08/18/2017 13:05:48

    Summer rumblings could herald a stormy fall for U.S. stocks

    NEW YORK (Reuters) - The Trump-fed rally in stocks, lately showing signs of faltering as the long Wall Street summer nears its end, faces a key test in the weeks ahead with the approach of a historically unkind season for equities and a clutch of issues - such as raising the debt ceiling - awaiting the return of lawmakers to Washington.

  • 08/15/2017 10:41:07

    Merkel rival Schulz attacks her "zig zag" German car policy

    BERLIN, Aug 15 (Reuters) - Angela Merkel's main challenger in next month's German election criticised the chancellor's approach to carmakers on Tuesday and called for them to pay for the widening emissions scandal.

  • 08/14/2017 21:45:35

    Trump orders review of China's trade practises

    The president asks the top US trade official to review China's approach to intellectual property.

  • 08/14/2017 14:47:28

    Trump authorises possible China trade investigation

    The president asks the top US trade official to review China's approach to intellectual property.

  • 08/10/2017 09:32:33

    BRIEF-Noble Group rebuffed takeover approach from Centricus- FT, citing sources

    * Noble Group rebuffed takeover approach from Centricus- FT, citing sources Source http://on.ft.com/2vIrEcP

  • 08/07/2017 13:10:00

    Why Limelight Networks, Inc. Shares Rose 18% in July

    The content delivery specialist's quality-based sales approach exceeded expectations in the second quarter, and the fruitful turnaround story is set to continue.

  • 08/01/2017 18:38:28

    Carl E. Reichardt, Leader of Wells Fargo in the 1980s and ’90s, Dies at 86

    Mr. Reichardt introduced a leaner approach to commercial banking that served as a model for the industry.

  • 07/31/2017 23:04:14

    Seed funding slows in Silicon Valley

    SAN FRANCISCO, August 1 (Reuters) - The bloom is off seed funding, the business of providing money to brand-new startups, as investors take a more measured approach to financing emerging U.S. technology companies.

  • 07/27/2017 07:37:43

    Stock market opens at all-time intraday highs

    U.S. stock-index benchmarks on Thursday jumped to records at the open, supported by the latest round of upbeat corporate results. Most recently Facebook Inc. reported second-quarter results late-Wednesday that beat expectations, helping it approach a market value of $500 million. Enthusiasm around Facebook helped to lift the broader technology industry . The Dow Jones Industrial Average rose to an all-time intraday high and was most recently up 0.2% at 21,763, the S&P 500 index climbed 0.2% at 2,481, while the tech-laden Nasdaq Composite Index rose 0.5% at 6,453. Separately, Twitter Inc. shares were plunging after it reported lackluster user growth in its recent quarterly report. Shares of the microblogging platform were down about 13%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    Apricus Biosciences, IncAPRI | Aptose Biosciences, Inc.APTO | Aqua Metals, Inc.AQMS | Aquinox Pharmaceuticals, Inc.AQXP | AR Capital Acquisition Corp.AUMA | AR Capital Acquisition Corp.AUMAU | AR Capital Acquisition Corp.AUMAW | Aradigm CorporationARDM | Aratana Therapeutics, Inc.PETX | Arbutus Biopharma CorporationABUS |